{"id":"W2054541910","doi":"10.1007/s10549-010-1232-1","title":"The PI3 kinase/mTOR blocker NVP-BEZ235 overrides resistance against irreversible ErbB inhibitors in breast cancer cells","year":2010,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":60,"is_retracted":false,"has_abstract":true,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"PI3K/AKT/mTOR pathway; ErbB; Lapatinib; Protein kinase B; Erlotinib; Cancer research; Gefitinib; Breast cancer; Pharmacology; EGFR inhibitors; Drug resistance; Medicine; Cancer; Phosphorylation; Biology; Signal transduction; Internal medicine; Epidermal growth factor receptor; Trastuzumab; Cell biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004717942,0.0003495901,0.000259056,0.0001179663,0.0005114728,0.0001551937,0.0003614335,0.0002150041,0.0001159023],"category_scores_gemma":[0.00001901658,0.0002516251,0.0001076473,0.0003493401,0.0005765212,0.00001894143,0.0001980439,0.0004165536,0.00001420609],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004562194,"about_ca_system_score_gemma":0.0008442004,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004780147,"about_ca_topic_score_gemma":0.03107043,"domain_scores_codex":[0.997265,0.0001411139,0.0003015209,0.0008063494,0.0005235186,0.0009624337],"domain_scores_gemma":[0.9985234,0.00009038008,0.00009556456,0.0006622768,0.0002986216,0.0003297932],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.002661671,0.0005209546,0.05763752,0.00006896216,0.000346511,0.00008361593,0.0001978986,0.00006448933,0.8516596,0.000109416,0.03030746,0.05634193],"study_design_scores_gemma":[0.004953567,0.0004602794,0.07495138,0.0003981893,0.00005580071,0.00005091579,0.0003935696,0.00005720824,0.5888725,0.0002050648,0.3287606,0.000840949],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9840329,0.00863258,0.000001514218,0.004216881,0.00060153,0.000631118,0.001037597,0.00001936098,0.0008265298],"genre_scores_gemma":[0.9837567,0.01037498,0.00006243923,0.0001219489,0.00107325,0.0005726744,0.00003784385,0.00005657442,0.003943576],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2984532,"threshold_uncertainty_score":0.9999936,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01660315909393041,"score_gpt":0.3102526844706381,"score_spread":0.2936495253767077,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}